Inventor · disambiguated record
Ettore Appella
Also filed as: APPELLA ETTORE
19 granted patents·6 pending applications·258 citations·filing 1988–2022
95Inventor score
Files withUS HEALTH14CANCERFORSKNINGSFONDET AF 19892APPELLA DANIEL1BROOKHAVEN SCIENCE ASS LLC1INMAN JOHN K1
Top patents by PatentIndex Score
25 records- 0190US5698196AAntibodies specific for neutrophic chemotactic factorUS HEALTH·Filed 1995·Granted Dec 16, 1997·58 cites·11 claims
- 0274US7319091B2Human derived monocyte attracting purified protein product useful in a method of treating infection and neoplasms in a human body, and the cloning of full length cDNA thereofUS SEC DEP OF HEALTH AND HUMAN·Filed 2005·Granted Jan 15, 2008·2 cites·7 claims
- 0370US5652338ANeutrophil chemotactic factorUS HEALTH·Filed 1988·Granted Jul 29, 1997·15 cites·1 claims
- 0469US6309863B1Methods for generating phosphorylation site-specific immunological reagentsBROOKHAVEN SCIENCE ASS LLC·Filed 1999·Granted Oct 30, 2001·21 cites·32 claims
- 0569US5532144AProcess for preparing human derived monocyte attracting purified peptide products useful in a method of treating infection and neoplasms in a human bodyUS HEALTH·Filed 1995·Granted Jul 2, 1996·16 cites·6 claims
- 0668US5925352AMethod of treating inflammation with antibodies to neutrophil chemotactic factorUS HEALTH·Filed 1997·Granted Jul 20, 1999·12 cites·2 claims
- 0765US7625917B2Thiolesters and uses thereofTURPIN JAMES A·Filed 2003·Granted Dec 1, 2009·5 cites·8 claims
- 0863US5714578AHuman derived monocyte attracting purified protein product useful in a method of treating infection and neoplasms in a human bodyUS HEALTH·Filed 1995·Granted Feb 3, 1998·23 cites·2 claims
- 0960US6475741B1Neutrophil chemotactic factor cloned cDNA and monoclonal antibodies theretoUS HEALTH·Filed 2001·Granted Nov 5, 2002·0 cites·2 claims
- 1060US6248712B1Urokinase-type plasminogen activator receptorCANCERFORSKNINGSFONDET AF 1989·Filed 1995·Granted Jun 19, 2001·29 cites·28 claims
- 1159US7456268B2Materials and methods for inhibiting Wip1US HEALTH·Filed 2007·Granted Nov 25, 2008·0 cites·2 claims
- 1259US6090795AHuman derived monocyte attracting purified peptide products useful in a method of treating infection and neoplasms in a human bodyUS HEALTH·Filed 1991·Granted Jul 18, 2000·18 cites·15 claims
- 1359US5891664AVectors and methods for recombinant production of uPA-binding fragments of the human urokinase-type plasminogen receptor (uPAR)CANCERFORSKNINGSFONDET AF 1989·Filed 1994·Granted Apr 6, 1999·23 cites·22 claims
- 1458US6869924B1Human derived monocyte attracting purified protein product useful in a method of treating infection and neoplasms in a human body, and the cloning of full length cDNA thereofUS HEALTH·Filed 1989·Granted Mar 22, 2005·16 cites·12 claims
- 1557US2009074724A1Materials and methods for inhibiting wip1US GOV HEALTH & HUMAN SERV·Filed 2008·Application pending·0 cites
- 1656US7528274B2Acylthiols and component thiol compositions as anti-HIV and anti-retroviral agentsUS HEALTH·Filed 2002·Granted May 5, 2009·2 cites·26 claims
- 1756US6376659B1Nucleic acids encoding a novel neutrophil chemotactic factorNASA·Filed 1997·Granted Apr 23, 2002·11 cites·6 claims
- 1855US2024277829A1Hiv-1 vaccination and samt-247 microbicide to prevent hiv-1 infectionUS HEALTH·Filed 2022·Application pending·0 cites
- 1949US6706729B1Thiolesters and uses thereofUS HEALTH·Filed 1999·Granted Mar 16, 2004·4 cites·11 claims
- 2048US8076372B2Acythiols and component thiol compositions as anti-HIV and anti-retroviral agentsINMAN JOHN K·Filed 2009·Granted Dec 13, 2011·0 cites·17 claims
- 2147US2005037360A1Materials and methods for inhibiting wip1US HEALTH·Filed 2003·Application pending·0 cites
- 2246US2010256098A1Compounds for inhibiting wip1, prodrugs and compositions thereof, and related methodsUS HEALTH·Filed 2008·Application pending·0 cites
- 2339US2003027981A1Urokinase-type plasminogen activator receptorFiled 2001·Application pending·0 cites
- 2436US2013096092A1Thioether prodrug compositions as anti-hiv and anti-retroviral agentsAPPELLA DANIEL·Filed 2011·Application pending·0 cites
- 2532US6514493B1cDNA clone for tumor rejection antigen gp110 and tumor peptide vaccineUNIV PITTSBURGH·Filed 1997·Granted Feb 4, 2003·3 cites·7 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →